摘要
尽管许多基因突变和分子机制被认为参与了肌萎缩侧索硬化症(ALS),但是如此严重的神经退行性紊乱仍然缺乏实质性治疗。本文不是对潜在治疗方法进行概述,而是侧重关注新颖的分子机制的新研究发现,创新的分子机制在发展未来的ALS疗法中显示一定前景。本文中特别强调了自我吞噬状态和在错误折叠蛋白形成中聚合的那些自我吞噬基质。实际上,就如本文第一部分概述,家族ALS症的多数的基因突变中会发生自我吞噬通路变异。这些突变减少自我吞噬基质的清除,从而导致巨大的变异线粒体和错误折叠蛋白的积聚。因此,这篇综述主要致力于介绍错误折叠蛋白非常规加工导致的非正常的蛋白质类分泌物,该分泌物可能构成ALS神经病理学在细胞间扩散的一种成分。为了了解未来研究中的潜在治疗靶点,对调节这些步骤的重要机制进行了分析。同时,鉴于新型疾病致病机制,关于最近实验的阴性结果我们也进行了解释。在本章的最后一部分,我们讨论了与脊髓和相关运动区域的细胞间壁操作毒性机制相关的局灶性干细胞移植替代疗法。
关键词: 糖基化终产物(AGEs);肌萎缩侧索硬化症(ALS);自我吞噬;错误折叠蛋白;线粒体;prionoids;闰绍细胞;干细胞疗法
Current Medicinal Chemistry
Title:Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Volume: 21 Issue: 31
Author(s): Livia Pasquali, Paola Lenzi, Francesca Biagioni, Gabriele Siciliano and Francesco Fornai
Affiliation:
关键词: 糖基化终产物(AGEs);肌萎缩侧索硬化症(ALS);自我吞噬;错误折叠蛋白;线粒体;prionoids;闰绍细胞;干细胞疗法
摘要: Despite a number of genetic mutations and molecular mechanisms are recognized to participate in amyotrophic lateral sclerosis (ALS), such a devastating neurological disorder still lacks a substantial cure. The present manuscript rather than a general overview of potential therapeutic approaches focuses on novel research findings detailing novel molecular mechanisms which appear to be promising for developing future ALS therapeutics. A special emphasis is given to the abnormal autophagy status and to those autophagy substrates which aggregate in the form of misfolded proteins. In fact, as reviewed in the first part of the manuscript, altered autophagy pathway is present in most genetic mutations responsible for familial ALS. These mutations impair clearance of autophagy substrates, which determines accumulation of giant altered mitochondria and misfolded proteins. Therefore, a considerable piece of the review is dedicated to unconventional processing of misfolded proteins leading to unconventional protein secretions which may underlie a prionoid cell to- cell spreading of ALS neuropathology. The intimate mechanisms regulating these steps are analyzed in order to comprehend which potential therapeutic targets might be considered in future studies. At the same time, negative findings concerning recent trials are explained in light of novel disease mechanisms. In the final part of the review the replacement therapy with focal stem cells implantation is discussed in relationship with toxic mechanisms operating in the intercellular space of the spinal cord and motor-related areas.
Export Options
About this article
Cite this article as:
Pasquali Livia, Lenzi Paola, Biagioni Francesca, Siciliano Gabriele and Fornai Francesco, Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease, Current Medicinal Chemistry 2014; 21 (31) . https://dx.doi.org/10.2174/0929867321666140601161534
DOI https://dx.doi.org/10.2174/0929867321666140601161534 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Semaphorins at the Interface of Development and Cancer
Current Drug Targets Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening
Current Pharmaceutical Design Mitophagy in Carcinogenesis and Tumour Progression- A New Paradigm with Emerging Importance
Anti-Cancer Agents in Medicinal Chemistry Cardiovascular-Active Venom Toxins: An Overview
Current Medicinal Chemistry Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Realization Methods of Computer-aided Diagnosis System of Medical Images
Recent Patents on Engineering Hereditary Papillary Renal Carcinoma Type I
Current Molecular Medicine Current Perspectives in Ultra-sensitive Detection of Cancer-specific Biomarkers and Therapeutic Targets
Current Cancer Drug Targets A Novel Gene Selection Method Based on Sparse Representation and Max-Relevance and Min-Redundancy
Combinatorial Chemistry & High Throughput Screening Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Functions of Heparanase in Human Diseases
Mini-Reviews in Medicinal Chemistry Pharmacological Drug Delivery Strategies for Improved Therapeutic Effects: Recent Advances
Current Pharmaceutical Design Cyclophilins in Atherosclerosis: A New Therapeutic Target?
Current Pharmaceutical Design Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry Inflammation as Treatment Target for Status Epilepticus
Current Neuropharmacology Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder
Current Medicinal Chemistry Editorial [Hot topic: Current Formulations and Techniques of Drug/gene Delivery for Targeted Therapy and Tissue Engineering (Executive Editors: Chi-Hwa Wang and Sudhir H. Ranganath)]
Current Pharmaceutical Design Apoptin, A Versatile Protein with Selective Antitumor Activity
Current Medicinal Chemistry Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers
Current Pharmaceutical Biotechnology Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry